Introduction
MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino acid peptide encoded within the mitochondrial genome — specifically within the 12S ribosomal RNA gene. With the sequence Tyr-Arg-Trp-Leu-His-Glu-Ile-Ile-Asp-Ser-Phe-Leu-Glu-Glu-Leu-Arg-Arg-Arg, MOTS-C was first identified and characterised by Changhan David Lee and colleagues at the University of Southern California in 2015, representing a significant discovery in the field of mitochondrial biology.
MOTS-C belongs to a class of peptides known as mitochondria-derived peptides (MDPs) — short bioactive peptides encoded within the mitochondrial genome that act as signalling molecules, coordinating mitochondrial and nuclear gene expression in response to metabolic stress. All MOTS-C products supplied by Alpha Peptides are intended strictly for in vitro and laboratory research use only.
Structure & Background
The discovery of MOTS-C challenged the long-held assumption that the mitochondrial genome encodes only 13 proteins (all components of the oxidative phosphorylation machinery), 22 tRNAs, and 2 rRNAs. The identification of small open reading frames within mitochondrial rRNA genes has opened a new field of research into mitochondria-derived peptides as intercellular and intracellular signalling molecules.
MOTS-C is produced in mitochondria and can translocate to the nucleus, where it regulates nuclear gene expression in response to metabolic stress. It is also secreted into the circulation, where it acts as a hormone-like signalling molecule, with circulating levels varying in response to exercise, age, and metabolic status.
Proposed Mechanisms of Action
- AMPK activation: MOTS-C's primary signalling mechanism involves activation of AMP-activated protein kinase (AMPK), the master regulator of cellular energy homeostasis. AMPK activation by MOTS-C promotes glucose uptake, fatty acid oxidation, and mitochondrial biogenesis while inhibiting anabolic processes that consume ATP. This positions MOTS-C as a key mediator of the cellular response to energy stress.
- Folate cycle and AICAR pathway: Research has shown that MOTS-C inhibits the folate cycle, leading to accumulation of AICAR (5-aminoimidazole-4-carboxamide ribonucleotide), an endogenous AMPK activator. This indirect AMPK activation mechanism is distinct from direct AMPK activators and may have different downstream effects.
- Nuclear translocation and gene regulation: Under stress conditions, MOTS-C translocates from mitochondria to the nucleus, where it binds to the antioxidant response element (ARE) and regulates the expression of stress-response genes. This mitochondria-to-nucleus signalling represents a novel form of retrograde communication.
- Insulin sensitisation: MOTS-C has been shown to improve insulin sensitivity in skeletal muscle by promoting GLUT4 translocation to the cell surface and enhancing glucose uptake independently of insulin signalling, with AMPK activation proposed as the primary mechanism.
- Anti-inflammatory activity: Research has reported that MOTS-C modulates inflammatory signalling, including inhibition of NF-κB activity and reduction of pro-inflammatory cytokine expression, which may contribute to its metabolic and longevity-associated effects.
Key Research Findings
Metabolic Research
The foundational MOTS-C study (Lee et al., 2015, Cell Metabolism) demonstrated that MOTS-C treatment prevented and reversed diet-induced obesity and insulin resistance in mouse models, with effects mediated through AMPK activation and improved skeletal muscle glucose metabolism. These findings established MOTS-C as a significant research tool for studying metabolic regulation.
Exercise & Physical Performance Research
Research has investigated MOTS-C in the context of exercise physiology, with studies reporting that MOTS-C levels increase in response to exercise and that exogenous MOTS-C treatment improves exercise capacity in aged mice. A study published in Nature Aging (2021) reported that MOTS-C administration improved physical performance and metabolic health in aged mice, with effects comparable to those of exercise training.
Ageing & Longevity Research
Circulating MOTS-C levels have been reported to decline with age in both rodents and humans, and higher MOTS-C levels have been associated with longevity in human population studies. Research in aged animal models has reported that MOTS-C treatment improves multiple hallmarks of metabolic ageing, including insulin sensitivity, mitochondrial function, and inflammatory status.
Insulin Resistance & Type 2 Diabetes Models
Multiple studies have investigated MOTS-C in models of insulin resistance and type 2 diabetes, consistently reporting improvements in glucose homeostasis, insulin sensitivity, and pancreatic beta cell function. These findings have positioned MOTS-C as a research tool of significant interest in metabolic disease research.
Stress Response Research
Research has explored MOTS-C's role in the cellular stress response, with studies reporting that MOTS-C is upregulated in response to various forms of metabolic stress and acts to restore energy homeostasis. This positions MOTS-C as part of a broader mitochondrial stress signalling network alongside other MDPs.
MOTS-C in the Context of Mitochondria-Derived Peptides
MOTS-C is one of several mitochondria-derived peptides (MDPs) that have been identified in recent years, alongside Humanin and the SHLP (Small Humanin-Like Peptide) family. These peptides collectively represent a new paradigm in mitochondrial biology — the mitochondrial genome as a source of bioactive signalling molecules that coordinate systemic responses to metabolic stress and ageing. MOTS-C is distinguished from other MDPs by its AMPK-mediated metabolic effects and its exercise-responsive circulating levels.
Research Considerations
- MOTS-C is a relatively recently discovered peptide (2015), and the research field is still developing. The mechanistic picture continues to evolve as new studies are published.
- Its dual role as an intracellular signalling molecule (nuclear translocation) and a circulating hormone-like peptide means that experimental context (in vitro vs in vivo) is particularly important when interpreting findings.
- Circulating MOTS-C levels vary with age, exercise status, and metabolic health — relevant context for in vivo research protocol design.
- Refer to the Certificate of Analysis (COA) supplied with each batch for purity and sequence confirmation data.
Reconstitution & Storage
MOTS-C should be reconstituted with bacteriostatic water to the required concentration. Store the reconstituted solution at 2–8°C and use within 28–30 days. For full guidance, refer to our Peptide Reconstitution Guide and Storage & Handling Guide.
Research Resources
Researchers can source MOTS-C 10mg from Alpha Peptides, supplied with a full batch-specific COA. For related compounds studied in mitochondrial biology and metabolic research, explore our Mitochondrial Research and Metabolic Research collections. For a related mitochondria-targeted peptide with a complementary mechanism, see our SS-31 Research Overview.
Disclaimer: All products sold by Alpha Peptides are intended strictly for in vitro research and laboratory use only. They are not approved for human or veterinary use, and this article does not constitute medical advice.
0 comments